Sodium arsenite-induced stress-related gene expression in normal human epidermal, HaCaT, and HEL30 keratinocytes

Environmental Health Perspectives

Volumn 110, Issue SUPPL. 5, 2002, Pages 761-766

  Trouba, Kevin J ^a   Geisenhoffer, Kristen M ^a   Germolec, Dori R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Arsenite; Glutathione; Keratinocyte; Redox; Toxicity

Indexed keywords

ARSENITE SODIUM; BUTHIONINE SULFOXIMINE; GLUTATHIONE REDUCTASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OXIDOREDUCTASE; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ARTICLE; CANCER RISK; CELL IMMORTALIZATION; CHEMICAL CARCINOGENESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALIA; RODENTIA;

EID: 0036803057     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.02110s5761     Document Type: Article

References (72)

1. Yuspa SH. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. J Dermatol Sci 17(1):1-7(1998).
2. Leigh IM, Purkis PE, Markey A, Collins P, Neill S, Proby C, Glover M, Lane EB. Keratinocytes alterations in skin tumour developement. Recent Results Cancer Res 128:179-191 (1993).
3. Morikawa T, Wanibuchi H, Morimura K, Ogawa M, Fukushima S. Promotion of skin carcinogenesis by dimethylasinic acid in keratin (K6)/ODC transgenic mice. Jpn J Cancer Res 91(6):579-581 (2000).
4. Corsini E, Asti L, Viviani B, Marinovich M, Galli CL. Sodium arsenate induces overproduction of interleukin-1alpha in murine keratinocytes: role of mitochondria. J Invest Dermatol 113(5):760-765 (1999).
5. Hamadeh HK, Vargas M, Lee E, Menzel DB, Arsenic disrupts cellular levels of p53 and mdm2: a potential mechanism of carcinogenesis. Biochem Biophys Res Commun 263(2):446-449 (1999).
6. Germolec DR, Spalding J, Boorman GA, Wilmer JL, Yoshida T, Simeonova PP, Bruccoleri A, Kayama F, Gaido K, Tennant R, et al. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat Res 386(3):209-218 (1997).
7. Germolec DR, Yoshida T, Gaido K, Wilmer JL, Simeonova PP, Kayama F, Burleson F, Dong W, Lange RW, Luster MI. Arsenic induces overexpression of growth factors in human keratinocytes. Toxicol Appl Pharmacol 141(1):308-318 (1996).
8. Yen HT, Chiang LC, Wen KH, Chang SF, Tsai CC, Yu CL, Yu HS, Arsenic induces interleukin-8 expression in cultured keratinocytes. Arch Dermatol Res 288(11):716-717 (1996).
9. Luster MI, Wilmer JL, Germolec DR, Spalding J, Yoshida T, Gaido K, Simeonova PP, Burleson FG, Bruccoleri A. Role of keratinocyte-derived cytokines in chemical toxicity. Toxicol Lett 82-83:471-476 (1995).
10. Chen H, Liu J, Zhao CQ, Diwan BA, Merrick BA, Waalkes MP. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicol Appl Pharmacol 175(3):260-268 (2001).
11. Chen H, Liu J, Merrick BA, Waalkes MP. Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology. Mol Carcinog 30(2):79-87 (2001)
12. Mass MJ, Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res 386(3):263-277 (1997).
13. Vogt BL, Rossman TG. Effects of arsenite on p53, p21 and cyclin D expresssion in normal human fibroblasts-a possible mechanism for arsenite's comutagenicity. Mutat Res 478(1-2):159-168 (2001).
14. Rossman TG, Uddin AN, Burns FJ, Bosland MC. Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis. Toxicol Appl Pharmacol 176(1):64-71 (2001).
15. Dulout FN, Grillo CA, Seoane AI, Maderna CR, Nilsson R, Vahter M, Darroudi F, Natarajan AT. Chromosomal aberrations in peripheral blood lymphocytes form native Andean women and children from northwestern Argentina exposed to arsenic in drinking water. Mutat Res 370(3-4):151-158 (1996).
16. Trouba KJ, Wauson EM, Vorce RL. Sodium arsenite-induced dysregulation of proteins involved in proliferative signaling. Toxicol Appl Pharmacol 164(2):161-170 (2000).
17. Matsui M, Nishigori C, Toyokuni S, Takada J, Akaboshi M, Ishikawa M, Imamura S, Miyachi Y. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hyroxy-2′-deoxyguanosine in arsenic-related Bowen's disease. J Invest Dermatol 113(1):26-31 (1999).
18. Buzard GS, Kasprzak KS. Possible roles of nitric oxide and redox cell signalling in metal-induced toxicity and carcinogenesis: a review. J Environ Pathol Toxicol Oncol 19(3):179-199 (2000).
19. Yamanaka K, Mizol M, Kato K, Hasegawa A, Nakano M, Okada S. Oral administration of dimethylarsinic acid, a main metabolite or inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter. Biol Pharm Bull 24(5):510-514 (2001).
20. Pott WA, Benjamin SA, Yang RS. Pharmacokinetics, metabolism, and carcinogenicity of arsenic. Rev Environ Contam Toxicol 169:165-214 (2001).
21. Barchowsky A, Klei LR, Dudek EJ, Swatz HM, James PE. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic Biol Med 27(11-12):1405-1412 (1999).
22. Wang TS, Shu YF, Liu YC, Jan KY, Huang H. Glutathione peroxidase and catalase modulate the genotoxicity of arsenite. Toxicology 121(3):229-237 (1997).
23. Liu F, Jan KY. DNA damage in arsenite- and cadmium-treated bovine aortic endothelial cells. Free Radic Biol Med 28(1):55-63 (2000).
24. Lynn S, Gurr JR, Lai HT, Jan KY. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular muscle cells. Circ Res 86(5):514-519 (2000).
25. Hei TK, Liu SX, Waldren C. Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc Natl Acad Sci USA 95(14):8103-8107 (1998)
26. Lee TC, Ho IC. Modulation of cellular antioxidant defense activities by sodium arsenite in human fibroblasts. Arch Toxicol 69(7):498-504 (1995).
27. Chouchane S, Snow ET. In vitro effect of arsenical compounds on glutahione-related enzymes. Chem Res Toxicol 14(5):517-522 (2001).
28. Hamadeh H, Trouba K, Amin R, Afshari C, Germolec D. Coordination of altered DNA repair and damage pathways in arsenite exposed keratinocytes. Toxicol Sci (in press).
29. Ochi T. Kaise T, Oya-Ohta Y. Glutahione plays different roles in the induction of the cytotoxic effects of inorganic and organic arsenic compounds in cultured BALB/c 3T3 cells. Experientia 50(2):115-120 (1994).
30. Chang WC, Chen SH, Wu HL, Shi GY, Murota S, Morita I. Cytoprotective effect of reduced glutathione in arsenical-induced endothelial cell injury. Toxicology 69(1):101-110 (1991).
31. Oguro T, Hayashi M, Numazawa S, Asakawa K, Yoshida T. Heme oxygenase-1 gene expression by a glutathione depletor, phorone, mediated through AP-1 activation in rats. Biochem Biophys Res Commun 221(2):259-265 (1996).
32. Tanaka C, Kamata H, Takeshita H, Yagisawa H, Hirata H. Redox regulation of lipopolysaccharide (LPS)-induced interleukin-8 (IL-8) gene expression mediated by NF kappa B and AP-1 in human astrocytoma U373 cells. Biochem Biophys Res Commun 232(2):568-573 (1997).
33. Shimuzu M, Hochadel JF, Fulmer BA, Waalkes MP. Effect of glutathione depletion and metallothionein gene expression on arsenic-induced cytotoxicity and c-myc expression in vitro. Toxicol Sci 45(2):204-211 (1998).
34. Oya-Ohta Y, Kaise T, Ochi T. Induction of chromosomal aberrations in cultured human fibroblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction. Mutat Res 357(1-2):123-129 (1996).
35. Bae DS, Gennings C, Carter WH Jr, Yang RS, Campain JA. Toxicological interactions among arsenic, cadmium, chromium, and lead in human keratinocytes. Toxicol Sci 63(1):132-142 (2001).
36. Germolec DR, Spalding J, Yu HS, Chen GS, Simeonova PP, Humble MC, Bruccoleri A, Boorman GA, Foley JF, Yoshida T, et al. Arsenic enchancement of skin neoplasia by chronic stimulation of growth factors. Am J Pathol 153(6):1775-1785 (1998).
37. Goldman R, Moshonov S, Zor U. Generation of reactive oxygen species in a human keratinocyte cell line: role of calcium. Arch Biochem Biophys 350(1):10-18 (1998).
38. Assefa Z, Garmyn S, Bouillon R, Merlevede W, Vandenheede JR, Agostinis P. Differential stimulation of ERK and JNK activities by ultraviolet B irradiation and epidermal growth factor in human keratinocytes. J Invest Dermatol 108(6):886-891 (1997).
39. Gniadecki R, Thorn T, Vicanova J, Petersen A, Wulf HC. Role of mitchondria in ultraviolet-induced oxidative stress. J Cell Biochem 80(2):216-222 (2000).
40. Thraves P, Salehi Z, Dritschilo A, Rhim JS. Neoplastic transformation of immortalized human epidermal keratinocytes by ionizing radiation. Proc Natl Acad Sci USA 87(3):1174-1177 (1990).
41. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106(3):761-771 (1988).
42. Corsini E, Marinovich M, Galli CL. In vitro keratinocytes responses to chemical allergens. Boll Chim Farm 134(10):569-573 (1995).
43. Corsini E, Schubert C, Marinovich M, Galli CL. Role of mitochondria in tributyltin-induced interleukin-1 alpha production in murine keratinocytes. J Invest Dermatol 107(5):720-725 (1996).
44. Marks F, Hanke B, Thastrup O, Furstenberger G. Stimulatory effect of thapsigargin, a non-TPA-type tumor promoter, on archidonic acid metabolism in the murine keratinocyte line HEL30 and on epidermal cell proliferation in vivo as compared to the effects of phorbol ester TPA. Carcinogenesis 12(8):1491-1497 (1991).
45. Gschwendt M, Kittstein W, Mark F, Cyclosporin A inhibits phorbol ester-induced cellular proliferation and tumor promotion as well as phosphorylation of a 100-kd protein in mouse epidermis. Carcinogenesis 8(2):203-207 (1987).
46. Seemann D, Furstenberger G, Marks F. Effects of the skin mitogens tumor-promotor 12-O-tetradecanoylphorbol 13-acetate and divalent-cation-ionophore A23187 on ion fluxes and membrane potential in a murine epidermal cell line (HEL30) and in 3T3 fibroblasts. Eur J Biochem 137(3):485-494 (1983).
47. Hornung H, Bohnert A, Phan-Than L, Krieg T, Fusenig NE. Basement membrane formation by malignant mouse keratinocyte cell lines in organotypic culture and transplants: correlation with degree of morphologic differentiation. J Cancer Res Clin Oncol 113(4):325-341 (1987).
48. Trouba KJ, Glanzer JG, Vorce RL. Wild-type and Ras-transformed fibroblasts display differential mitogenic responses to transient sodium arsenite exposure. Toxicol Sci 50(1):72-81 (1999).
49. Lee TC, Ko JL, Jan KY. Differential cytotoxicity of sodium arsenite in human fibroblasts and Chinese hamster ovary cells. Toxicology 56(3):289-299 (1989).
50. Sordo M, Herrera LA, Ostrosky-Wegman P, Rojas E. Cytotoxic and genotoxic effects of As, MMA, and DMA on leukocytes and stimulated human lymphocytes. Teratog Carcinog Mutagen 21(4):249-260 (2001).
51. Petrick JS, Ayala-Fierro F, Cullen WR, Carter DE, Vasken Aposhian H. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol Appl Pharmacol 163(2):203-207 (2000).
52. Huang RN, Lee TC. Cellular uptake of trivalent arsenite and pentavalent arsenate in KB cell cultured in phosphate free medium. Toxicol Appl Pharmacol 136(2):243-249 (1996).
53. Rossman TG, Goncharova EI, Rajah T, Wang Z. Human cells lack the inducible tolerance to arsenite seen in hamster cells. Mutat Res 386(3):307-314 (1997).
54. Leccia MT, Richard MJ, Joanny-Crisci F, Beani JC, UV-A1 cytotoxicity and antioxidant defence in keratinocytes and fibroblasts. Eur J Dermatol 8(7):478-482 (1998).
55. Brown JL, Stowers L, Baer M, Trejo J, Coughlin S, Chant J. Human Ste20 homologue hPAK1 links GTPases to the JNK MAP kinase pathway. Curr Biol 6(5):598-605 (1996).
56. Frost JA, Xu S, Hutchison MR, Marcus S, Cobb MH. Actions of Rho family small G proteins and p21-activated protein kinases on mitogen-activated protein kinase family members. Mol Cell Biol 16(7):3707-3713 (1996).
57. Pombo CM, Bonventre JV, Molnar A, Kyriakis J, Force T. Activation of a human Ste20-like kinase by oxidant stress defines a novel stress response pathway. Embo J 15(17):4537-4546 (1996).
58. 2+]. J Biol Chem 272(46):29372-29379 (1997).
59. Chen NY, Ma WY, Huang C, Ding M, Dong Z. Activation of PKC is required for arsenite-induced signal transduction. J Environ Pathol Toxicol Oncol 19(3):297-305 (2000).
60. Joseph P, Jaiswal AK. NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc Natl Acad Sci USA 91(18):8413-8417 (1994).
61. Joseph P, Xie T, Xu Y, Jaiswal AK. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase): expression, regulation, and role in cancer. Oncol Res 6(10-11):525-32 (1994).
62. Jaiswal AK. Jun and Fos regulation of NAD(P)H:quinone oxidorreductase gene expression. Pharmacogenetics 4(1):1-10 (1994).
63. Cresteil T, Jaiswal AK. High levels of expression of the NAD(P)H:quinone oxidoreductase (NQ01) gene in tumor cells compared to normal cells of the same origin. Biochem Pharmacol 42(5):1021-1027 (1991).
64. Schlager JJ, Powis G. Cytosolic NAD(P)H:(quinone-acceptor) oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. Int J Cancer 45(3):403-409 (1990).
65. Garmyn M, Degreef H. Suppression of UVB-induced c-fos and c-jun expression in human keratinocytes by N-acetyl-cysteine. J Photochem Photobiol B 37(1-2):125-130 (1997).
66. Soriani M, Hejmadi V, Tyrrell RM. Modulation of c-jun and c-fos transcription by UVB and UVA radiations in human dermal fibroblast and KB cells. Photochem Photobiol 71(5):551-558 (2000).
67. Burleson FG, Simeonova PP, Germole DR, Luster MI. Dermototoxic chemical stimulate of c-jun and c-fos transcription and AP- 1 DNA binding in human keratinocytes. Res Commun Mol Pathol Pharmacol 93(2):131-148 (1996).
68. Parrish AR, Zheng XH, Turney KD, Younis HS, Gandolfi AJ. Enhanced transcription factor DNA binding and gene expression induced by arsenite or arsenate in renal slices. Toxicol Sci 50(1):98-105 (1999).
69. Simeonova PP, Wang S, Toriuma W, Kommineni V, Matheson J, Unimye N, Kayama F, Harki D, Ding M, Vallyathan V, et al. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res 60(13):3445-3453 (2000).
70. Barchowsky A, Dudek EJ, Treadwell MD, Wetterhahn KE. Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells. Free Radic Biol Med 21(6):783-790 (1996).
71. Roussell RR, Barchowsky A. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation. Arch Biochem Biophys 377(1):204-212 (2000).
72. Bergelson S, Pinkus R, Daniel V. Intracellular glutathione levels regulate Fos/Jun induction and activation of glutathione S-transferase gene expression. Cancer Res 54(1):36-40 (1994).